KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Incyte (INCY) Gains from Sales and Divestitures: 2011-2018

Historic Gains from Sales and Divestitures for Incyte (INCY) over the last 7 years, with Dec 2018 value amounting to $266,667.

  • Incyte's Gains from Sales and Divestitures rose 25.00% to $333,334 in Q3 2019 from the same period last year, while for Sep 2019 it was $333,334, marking a year-over-year increase of 25.00%. This contributed to the annual value of $266,667 for FY2018, which is 33.33% up from last year.
  • As of FY2018, Incyte's Gains from Sales and Divestitures stood at $266,667, which was up 33.33% from $200,000 recorded in FY2017.
  • Incyte's Gains from Sales and Divestitures' 5-year high stood at $363,179 during FY2014, with a 5-year trough of $133,333 in FY2015.
  • Its 3-year average for Gains from Sales and Divestitures is $200,000, with a median of $200,000 in 2017.
  • Its Gains from Sales and Divestitures has fluctuated over the past 5 years, first crashed by 63.29% in 2015, then skyrocketed by 50.00% in 2017.
  • Incyte's Gains from Sales and Divestitures (Yearly) stood at $363,179 in 2014, then plummeted by 63.29% to $133,333 in 2015, then remained steady at $133,333 in 2016, then skyrocketed by 50.00% to $200,000 in 2017, then soared by 33.33% to $266,667 in 2018.